Trademark applications and grants for Threshold Pharmaceuticals Inc. Threshold Pharmaceuticals Inc has 6 trademark applications. The latest application filed is for "HYPOXIN"
Patent Application | Date |
---|---|
PREDICTIVE BIOMARKER FOR HYPOXIA-ACTIVATED PRODRUG THERAPY 20180334716 - 15/528067 Elenbaas; Brian A. ;   et al. | 2018-11-22 |
AZIRIDINE CONTAINING DNA ALKYLATING AGENTS 20180169064 - 15/736285 Matteucci; Mark ;   et al. | 2018-06-21 |
TREATMENT OF CANCER 20170232017 - 15/443698 Kroll; Stewart | 2017-08-17 |
TH-302 SOLID FORMS AND METHODS RELATED THERETO 20170210769 - 15/326990 Duan; Jian-Xin ;   et al. | 2017-07-27 |
Anti-Cancer Therapies 20170157161 - 14/961543 Tidmarsh; George | 2017-06-08 |
NCAGE Code | 611G1 | THRESHOLD PHARMACEUTICALS, INC.!DBA A DEVELOPMENT STAGE ENTERPRISE |
CAGE Code | 611G1 | THRESHOLD PHARMACEUTICALS, INC. (A DEVELOPMENT STAGE ENTERPRISE) |
DUNS | 118822795 | THRESHOLD PHARMACEUTICALS, INC. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.